MedPath

Effect of alkaline water in treatment of gastroesophageal reflux

Phase 3
Conditions
Gastroesophageal reflux disease.
Gastro-esophageal reflux disease
Registration Number
IRCT20190305042935N2
Lead Sponsor
Shahre-kord University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
72
Inclusion Criteria

Symptoms of gastroesophageal reflux disease at least 2 times a week for at least 3 months
Age between 18 to 40 years

Exclusion Criteria

Any pathological problem associated with gastroesophageal reflux disease including Barrett's esophagus and malignancy
Having warning signs such as painful and difficulty swallowing, nausea, vomiting and fever

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean scores of gastrointestinal symptoms in GERD questionnaire. Timepoint: Before the intervention and six-week after intervention. Method of measurement: Gastroesophageal Reflux Disease (GERD) questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath